QNRX logo

Quoin Pharmaceuticals, Ltd. (QNRX)

Profile

Full Name

Quoin Pharmaceuticals, Ltd.

Ticker

NASDAQ: QNRX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

August 1, 2016

Indexes

Not included

Website

https://quoinpharma.com

Employees

3

Key Details

Price

$7.84(-8.73%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$67.17(-598.55% YoY)

PE ratio

-

Next earnings date

Nov 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $7.84
    QNRX price is $7.84

    30-Day Relative Volume

    1.50
    QNRX 30-day relative volume is 1.50

    Price Performance

    Price Today change

    -8.73%
    QNRX price is down -8.73% today

    Price YTD change

    -65.59%
    QNRX price is down -65.59% since January 1st

    Price 1-year change

    -61.25%
    QNRX price is down -61.25% year-on-year

    Price 3-year change

    -99.49%
    QNRX price is down -99.49% over the past 3 years

    Price Range

    Price All-time high

    $1.42M
    QNRX price is currently -100.00% below its historical high of $1.42 million

    Price 3-year low

    $5.01
    QNRX price is currently +56.49% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $4.61M
    QNRX market capitalization is $4.61 million

    Market cap 3-year change

    -73.68%
    QNRX market capitalization is down -73.68% over the past 3 years

    Market cap All-time high

    $39908.24B
    QNRX market capitalization is currently -100.00% below its historical high of $39908.24 billion

    Market cap sector rank

    8.72%
    QNRX market capitalization is higher than 8.72% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +417.33%
    QNRX shares outstanding is up +417.33% year-on-year

    Shares Outstanding 3-Year Change

    +5059.65%
    QNRX shares outstanding is up +5059.65% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.85
    QNRX beta is 0.85

    200-day SMA

    $11.14
    QNRX price is currently -29.60% below its 200-day simple moving average

    50-day SMA

    $7.74
    QNRX price is currently +1.26% above its 50-day simple moving average

    RSI

    70.86
    QNRX 14-day relative strength index is 70.86

    Volume

    1.50
    QNRX 30-day relative volume is 1.50

    ATR

    $0.47
    QNRX average true range is $0.47

    10-day Historical Volatility

    39.75%
    QNRX 10-day historical volatility is 39.75%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    QNRX annual revenue is $0.00

    Revenue Analysts estimate

    -
    QNRX annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    QNRX annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.79%
    QNRX annual revenue is higher than 28.79% of companies in Healthcare sector

    EPS

    EPS

    -$67.17
    QNRX annual earnings per share is -$67.17

    EPS Analysts estimate

    -$11.60
    QNRX annual earnings per share is currently +479.03% higher than the consensus analysts' forecast

    EPS 1-year change

    -598.55%
    QNRX annual earnings per share is down -598.55% year-on-year

    EPS Sector rank

    3.86%
    QNRX annual earnings per share is higher than 3.86% of companies in Healthcare sector

    Profit

    Gross profit

    -$100.50K
    QNRX annual gross profit is -$100.50 thousand

    Gross margin

    -
    QNRX annual gross profit margin value is unknown

    Operating profit

    -$9.57M
    QNRX annual operating income is -$9.57 million

    Operating margin

    -
    QNRX annual operating profit margin value is unknown

    Net income

    -$9.01M
    QNRX annual net profit is -$9.01 million

    Net margin

    -
    QNRX annual net profit margin value is unknown

    Expenses

    Total expenses

    $9.01M
    QNRX annual total expenses is $9.01 million

    Operating expenses

    $9.47M
    QNRX annual total operating expenses is $9.47 million

    Cost of goods sold

    $100.50K
    QNRX annual cost of goods sold is $100.50 thousand

    Selling, general & administrative expenses

    $0.00
    QNRX annual SGA is $0.00

    Depreciation and amortization

    $100.50K
    QNRX annual depreciation & amortization is $100.50 thousand

    Interest expense

    $0.00
    QNRX annual interest expense is $0.00

    Income tax

    $0.00
    QNRX annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$9.57M
    QNRX annual earnings before interest & taxes is -$9.57 million

    EBITDA

    -$9.47M
    QNRX annual EBITDA is -$9.47 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $15.71M
    QNRX annual total assets is $15.71 million

    Non current assets

    $783.30K
    QNRX annual long term assets is $783.30 thousand

    Current assets

    $14.93M
    QNRX annual total current assets is $14.93 million

    Cash and cash equivalents

    $14.06M
    QNRX annual cash & cash equivalents is $14.06 million

    Accounts receivable

    -
    QNRX annual accounts receivable value is unknown

    Inventory

    $0.00
    QNRX annual inventory is $0.00

    Liabilities

    Total liabilities

    $6.50M
    QNRX annual total liabilities is $6.50 million

    Long term liabilities

    $2.32M
    QNRX annual total long term liabilities is $2.32 million

    Current liabilities

    $4.18M
    QNRX annual total current liabilities is $4.18 million

    Accounts payable

    $905.70K
    QNRX annual accounts payable is $905.70 thousand

    Debt

    Total debt

    $0.00
    QNRX annual total debt is $0.00

    Total debt 1-year change

    0%
    QNRX annual total debt has remained unchanged year-on-year

    Long term debt

    $0.00
    QNRX annual long term debt is $0.00

    Short term debt

    $0.00
    QNRX annual short term debt is $0.00

    Equity & Capital

    Shareholders equity

    $9.20M
    QNRX annual stockholders equity is $9.20 million

    Book value

    $9.20M
    QNRX annual book value is $9.20 million

    Retained earnings

    -$55.17M
    QNRX annual retained earnings is -$55.17 million

    Working capital

    $10.75M
    QNRX annual working capital is $10.75 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$7.89M
    QNRX annual cash flow from operations is -$7.89 million

    Cash from operations 1-year change

    -0.64%
    QNRX annual cash flow from operations is down -0.64% year-on-year

    Cash from investing

    -$1.90M
    QNRX annual cash flow from investing activities is -$1.90 million

    Cash from investing 1-year change

    -186.92%
    QNRX annual cash flow from investing activities is down -186.92% year-on-year

    Cash from financing

    $11.02M
    QNRX annual cash flow from financing activities is $11.02 million

    Cash from financing 1-year change

    +111.79%
    QNRX annual cash flow from financing activities is up +111.79% year-on-year

    CAPEX

    CAPEX

    $0.00
    QNRX annual capital expenditures is $0.00

    CAPEX 1-year change

    0%
    QNRX annual capital expenditures has remained unchanged year-on-year

    Free Cash Flow

    Free cash flow

    -$7.89M
    QNRX annual free cash flow is -$7.89 million

    Free cash flow 1-year change

    -0.64%
    QNRX annual free cash flow is down -0.64% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    QNRX annual gross profit margin value is unknown

    Operating margin

    -
    QNRX annual operating profit margin value is unknown

    Net margin

    -
    QNRX annual net profit margin value is unknown

    ROA & ROE

    ROA

    -64.60%
    QNRX annual return on assets is -64.60%

    ROE

    -121.13%
    QNRX annual return on equity is -121.13%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    QNRX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    QNRX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.81
    QNRX price to book ratio is 1.81

    PB ratio Sector rank

    51.72%
    QNRX price to book ratio is higher than 51.72% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    QNRX price to sales ratio value is unknown

    PS ratio Sector rank

    -
    QNRX price to sales ratio is unknown

    Enterprise value

    Enterprise value

    -$3.18M
    QNRX enterprise value is -$3.18 million

    Enterprise value Sector rank

    7.87%
    QNRX enterprise value is higher than 7.87% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    0.25
    QNRX EV/EBITDA is 0.25

    EV/EBITDA Sector rank

    68.88%
    QNRX EV/EBITDA is higher than 68.88% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    3.57
    QNRX annual current ratio is 3.57

    Quick ratio

    3.57
    QNRX annual quick ratio is 3.57

    Leverage

    Debt to equity

    0.00
    QNRX annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    QNRX annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    QNRX piotroski f-score value is unknown

    Altman Z-Score

    -5.68
    QNRX altman z-score is -5.68

    Analyst ratings

    Recent major analysts updates

    Mar 15, 24 Maxim Group
    Buy
    Sep 7, 22 Alliance Global Partners
    Buy
    May 6, 22 Ladenburg Thalmann
    Buy
    Jan 7, 22 Maxim Group
    Buy
    Dec 15, 21 JMP Securities
    Market Outperform

    Institutional Ownership

    Screeners with QNRX included

    Growing Shares Outstanding
    US stocks
    Best performing stocks last month
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Quoin Pharmaceuticals, Ltd.?
    • Does Quoin Pharmaceuticals, Ltd. pay dividends?
    • What sector is Quoin Pharmaceuticals, Ltd. in?
    • What industry is Quoin Pharmaceuticals, Ltd. in?
    • What country is Quoin Pharmaceuticals, Ltd. based in?
    • When did Quoin Pharmaceuticals, Ltd. go public?
    • Is Quoin Pharmaceuticals, Ltd. in the S&P 500?
    • Is Quoin Pharmaceuticals, Ltd. in the NASDAQ 100?
    • Is Quoin Pharmaceuticals, Ltd. in the Dow Jones?
    • When was Quoin Pharmaceuticals, Ltd.'s last earnings report?
    • When does Quoin Pharmaceuticals, Ltd. report earnings?

    What is the ticker symbol for Quoin Pharmaceuticals, Ltd.?

    The ticker symbol for Quoin Pharmaceuticals, Ltd. is NASDAQ:QNRX

    Does Quoin Pharmaceuticals, Ltd. pay dividends?

    No, Quoin Pharmaceuticals, Ltd. does not pay dividends

    What sector is Quoin Pharmaceuticals, Ltd. in?

    Quoin Pharmaceuticals, Ltd. is in the Healthcare sector

    What industry is Quoin Pharmaceuticals, Ltd. in?

    Quoin Pharmaceuticals, Ltd. is in the Biotechnology industry

    What country is Quoin Pharmaceuticals, Ltd. based in?

    Quoin Pharmaceuticals, Ltd. is headquartered in United States

    When did Quoin Pharmaceuticals, Ltd. go public?

    Quoin Pharmaceuticals, Ltd.'s initial public offering (IPO) was on August 1, 2016

    Is Quoin Pharmaceuticals, Ltd. in the S&P 500?

    No, Quoin Pharmaceuticals, Ltd. is not included in the S&P 500 index

    Is Quoin Pharmaceuticals, Ltd. in the NASDAQ 100?

    No, Quoin Pharmaceuticals, Ltd. is not included in the NASDAQ 100 index

    Is Quoin Pharmaceuticals, Ltd. in the Dow Jones?

    No, Quoin Pharmaceuticals, Ltd. is not included in the Dow Jones index

    When was Quoin Pharmaceuticals, Ltd.'s last earnings report?

    Quoin Pharmaceuticals, Ltd.'s most recent earnings report was on August 7, 2025

    When does Quoin Pharmaceuticals, Ltd. report earnings?

    The next expected earnings date for Quoin Pharmaceuticals, Ltd. is November 7, 2025
    On this page